14:03:51 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
C-Rad är verksamma inom medicinteknik. Bolaget bedriver utveckling, tillverkning och försäljning av produkter och lösningar inom avancerad strålterapi. Verksamheten riktar sig huvudsakligen mot strålbehandlingskliniker där bolaget utöver kärnverksamheten erbjuder tillhörande installationstjänster och support. Kunderna återfinns på global nivå och huvudkontoret ligger i Uppsala.

Kalender

2020-01-31 Bokslutskommuniké 2019
2019-10-25 Kvartalsrapport 2019-Q3
2019-08-30 Kvartalsrapport 2019-Q2
2019-05-09 Ordinarie utdelning CRAD B 0.00 SEK
2019-05-08 Årsstämma 2018
2019-05-08 Kvartalsrapport 2019-Q1
2019-02-08 Bokslutskommuniké 2018
2019-01-31 Bokslutskommuniké 2018
2018-10-26 Kvartalsrapport 2018-Q3
2018-08-17 Kvartalsrapport 2018-Q2
2018-05-31 Årsstämma 2017
2018-05-18 Ordinarie utdelning CRAD B 0.00 SEK
2018-04-26 Kvartalsrapport 2018-Q1
2018-01-31 Bokslutskommuniké 2017
2017-10-27 Kvartalsrapport 2017-Q3
2017-08-16 Kvartalsrapport 2017-Q2
2017-05-02 Ordinarie utdelning CRAD B 0.00 SEK
2017-04-28 Kvartalsrapport 2017-Q1
2017-04-28 Årsstämma 2016
2017-02-13 Bokslutskommuniké 2016
2016-11-17 Extra Bolagsstämma 2016
2016-11-14 Kvartalsrapport 2016-Q3
2016-08-24 Kvartalsrapport 2016-Q2
2016-05-09 Kvartalsrapport 2016-Q1
2016-04-15 Ordinarie utdelning CRAD B 0.00 SEK
2016-04-14 Årsstämma 2015
2016-02-08 Bokslutskommuniké 2015
2015-11-06 Kvartalsrapport 2015-Q3
2015-08-14 Kvartalsrapport 2015-Q2
2015-05-08 Kvartalsrapport 2015-Q1
2015-04-17 Ordinarie utdelning CRAD B 0.00 SEK
2015-04-16 Årsstämma 2014
2015-01-30 Bokslutskommuniké 2014
2014-11-07 Analytiker möte 2014
2014-11-07 Kvartalsrapport 2014-Q3
2014-08-15 Kvartalsrapport 2014-Q2
2014-05-16 Kvartalsrapport 2014-Q1
2014-04-17 Ordinarie utdelning CRAD B 0.00 SEK
2014-04-16 Årsstämma 2013
2014-02-17 Bokslutskommuniké 2013
2013-11-28 Kvartalsrapport 2013-Q3
2013-11-01 Analytiker möte 2013
2013-10-30 Extra Bolagsstämma 2013
2013-09-02 15-7 2013
2013-08-30 Kvartalsrapport 2013-Q2
2013-06-03 Ordinarie utdelning CRAD B 0.00 SEK
2013-05-31 Årsstämma 2012
2013-05-29 Kvartalsrapport 2013-Q1
2013-02-26 Bokslutskommuniké 2012
2012-12-04 Extra Bolagsstämma 2012
2012-11-28 Kvartalsrapport 2012-Q3
2012-09-04 Kvartalsrapport 2012-Q2
2012-06-04 Ordinarie utdelning CRAD B 0.00 SEK
2012-06-01 Årsstämma 2011
2012-05-24 Kvartalsrapport 2012-Q1
2012-02-24 Bokslutskommuniké 2011
2011-11-25 Kvartalsrapport 2011-Q3
2011-08-26 Kvartalsrapport 2011-Q2
2011-05-26 Ordinarie utdelning CRAD B 0.00 SEK
2011-05-25 Årsstämma 2010
2011-05-24 Kvartalsrapport 2011-Q1
2011-02-11 Bokslutskommuniké 2010
2010-06-02 Ordinarie utdelning CRAD B 0.00 SEK
2010-06-01 Årsstämma 2009
2010-05-28 Kvartalsrapport 2010-Q1
2009-11-27 Kvartalsrapport 2009-Q3
2019-11-08 17:05:00

C-RAD today announces that as a result of violation of the Nasdaq Stockholm Rulebook for issuers, relating to the timing of publication of a press release in December 2017, the Disciplinary Committee at Nasdaq Stockholm has decided to impose disciplinary sanctions on C-RAD. The Disciplinary Committee instructs C-RAD to pay the stock exchange a fine of SEK 410.000, corresponding to 2 annual fees, as a result of violations regarding the rules on disclosure of inside information and capacity of providing information to the market.

For the decision in its entirety, reference is made to Nasdaq Stockholm's website.

Background
At 13:00 on December 12th, 2017, a company to which C-RAD is a subcontractor, published a press release with the meaning that the scope of a previously entered agreement had now decreased. C-RAD recognizes this press release during the afternoon of December the 12th and then initiates investigations leading to the conclusion that this also means that expected orders for C-RAD will decrease. The following morning, at 08:30 on December the 13th, C-RAD publishes a press release with this meaning.

Nasdaq has questioned the timing of the publication of this press release and has, according to a decision in the Disciplinary Committee, found that C-RAD has violated the rules for publishing inside information and capacity for providing information to the stock market.

Comments from C-RAD on the decision
C-RAD respects the views expressed by the Disciplinary Committee at Nasdaq Stockholm. C‑RAD disputes that the company did not have the capacity to provide information to the stock market. C-RAD admits that the company did not fulfil all requirements by the Market Abuse Regulation in order to apply the regulation’s possibility for delaying disclosure of inside information, thereby sharing the Disciplinary Committee’s conclusion that the press release on December the 13th, at 08:30, should have been published immediately when it was completed at 23:15 on December the 12th.

For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com

Om C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

Attachment